People with early Parkinson’s disease who received the oral therapy bezisterim in a Phase 2 clinical trial saw significant…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Long-term exposure to ozone, a form of air pollution, may increase the risk of developing Parkinson’s disease, according to…
Pretreatment with curcumin, a compound found in the spice turmeric, helped protect motor function in a mouse model of…
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to sasineprocel (ANPD001), an experimental…
Low dopamine levels disrupt nerve circuits in the brain in Parkinson’s disease — but a new study indicates that different…
Language-based analyses of how people with Parkinson’s disease tell stories may provide a more nuanced look at how…
A tablet-based set of video games called SmartMe&You reflected cognitive status in people with Parkinson’s-related mild cognitive impairment or…
Blood levels of certain protein markers previously linked to Alzheimer’s disease may help predict dementia risk in people with…
Older people with Parkinson’s disease who engage in regular exercise tend to perform worse on measures of physical fitness…
A newly developed yoga program designed specifically to improve mobility and mental well-being for people in the early stages of…